AUSTIN, Texas (AP) — Seven-time Tour de France winner Lance Armstrong is facing a key deadline in the U.S. Anti-Doping Agency drug case against him.
Armstrong must decide whether to challenge the sweeping doping allegations or accept sanctions that could include a lifetime ban from the sport and potentially strip his titles.
Armstrong strongly denies doping. The question is whether he will keep fighting USADA or officially give up and move on, risking a permanent stain on his legacy. Armstrong must decide by midnight Mountain time (2 a.m. EDT Friday).
Anti-doping officials say Armstrong used performance-enhancing drugs, including steroids and blood boosters, while winning the Tour de France from 1999-2005.